BC
Birchview Capital Portfolio holdings
AUM
$101M
This Quarter Return
-7.77%
1 Year Return
+34.62%
3 Year Return
+103.2%
5 Year Return
+107.72%
10 Year Return
+352.1%
AUM
$150M
AUM Growth
+$150M
(-9.5%)
Cap. Flow
+$2.02M
Cap. Flow
% of AUM
1.35%
Top 10 Holdings %
Top 10 Hldgs %
78.1%
Holding
51
New
–
Increased
6
Reduced
3
Closed
1
Top Buys
| 1 |
QuidelOrtho
QDEL
|
$1.69M |
| 2 |
BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
|
$1.12M |
| 3 |
Acadia Pharmaceuticals
ACAD
|
$371K |
| 4 |
ALBO
Albireo Pharma, Inc. Common Stock
ALBO
|
$334K |
| 5 |
AMRN
Amarin Corp
AMRN
|
$168K |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$769K |
| 2 |
AWH
Aspira Women's Health Inc. Common Stock
AWH
|
$638K |
| 3 |
NARI
Inari Medical, Inc. Common Stock
NARI
|
$207K |
| 4 |
Workhorse Group
WKHS
|
$177K |
Sector Composition
| 1 | Healthcare | 95.26% |
| 2 | Energy | 1.16% |
| 3 | Consumer Discretionary | 0.13% |
| 4 | Consumer Staples | 0.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Gilead Sciences
GILD
$140B
| – | – |
-10,000
| Closed | -$769K |
|